Your daily digital ally against sclerosis
EXPERTISES
The Biogen Group, an international healthcare and biotechnology company, selected BeTomorrow following a call for tenders to take over the development of its Cleo application, a digital companion for people suffering from a serious neurological pathology : multiple sclerosis.
BeTomorrow collaborated with Cleo to take over the design and development of an application (super-app) dedicated to providing personalized support in the areas of health, nutrition and medical monitoring for patients.
BeTomorrow focused its expertise on the consulting and development of the existing mobile application, as well as on the takeover and reversibility of the project. Our specialists chose to adopt pay-as-you-go strategies to target an ambitious roadmap, while at the same time establishing a qualitative foundation for the code, enabling the project to be built in a stable and robust context.
Of operational collaboration
Renewed confidence to meet tomorrow's healthcare challenges and improve the health of sclerosis patients.
Free features
Free access to reliable resources and wellness tips to monitor and improve daily life with MS.
Worldwide deployments
Personalized advice modules on sleep, physical activity, mood and communication.
CHALLENGES
Tech
BeTomorrow chose React Native to optimize the performance of the native application. Optimizations have been made to the Rest API for optimal bandwidth and latency. There was also a focus on React Native Bridge for advanced features.
Our Client
Facing the challenges of everyday life with multiple sclerosis (MS) is a reality for many people. Thanks to Cleo, a free mobile application specially designed to accompany and support those living with MS, patients benefit from a wealth of information, support and practical tools to help overcome the difficulties encountered in their daily lives.
